This is based on a high burden of pneumococcal disease in this population from a young age.1
Aboriginal and Torres Strait Islander adults aged ≥25 years who have previously received a dose of any pneumococcal vaccine (including 23vPPV, 13vPCV, 15vPCV or 20vPCV) are recommended to receive this dose of 21vPCV at least 12 months after their last dose.
Aboriginal and Torres Strait Islander adults aged 18–24 years who receive a dose of 21vPCV due to a risk condition, do not need another dose at 25 years of age.
21vPCV is funded through the NIP for all Aboriginal and Torres Strait Islander adults aged ≥25 years. For details see the National Immunisation Program Schedule.